supplementary materials for :"Clinical prioritization of adverse events associated with Hedgehog pathway inhibitors in basal cell carcinoma: Insights from the FDA Adverse Event Reporting System"

Name: supplementary materials for :"Clinical prioritization of adverse events associated with Hedgehog pathway inhibitors in basal cell carcinoma: Insights from the FDA Adverse Event Reporting System"
Creator: Zequn Qiu
Published: 2025-11-05T11:25:41.612Z
Keywords: Clinical Finding, Demographics, Disproportionality Analysis

Qiu, Zequn

doi:10.17632/6k53m8c9f4.3

supplementary materials for :"Clinical prioritization of adverse events associated with Hedgehog pathway inhibitors in basal cell carcinoma: Insights from the FDA Adverse Event Reporting System"

Published: 5 November 2025| Version 3 | DOI: 10.17632/6k53m8c9f4.3

Contributor:

Zequn Qiu

Description

This dataset contains supplementary materials from the article.

Files

Institutions

Chinese Academy of Medical Sciences and Peking Union Medical College Hospital and Institute of Dermatology

supplementary materials for :"Clinical prioritization of adverse events associated with Hedgehog pathway inhibitors in basal cell carcinoma: Insights from the FDA Adverse Event Reporting System"

Description

Files

Institutions

Categories

Licence